Pay in 4 interest-free payments of $6.62 Learn more
Ships within 48 hours · Estimated delivery Nov 9 - Nov 14
A consultation with a licensed clinician is the right starting point to understand what applies to your situation
As GLP-1 receptor agonists have become one of the most widely prescribed drug classes in the United States for weight loss and type 2 diabetes, hair loss has emerged as a real, documented, and increasingly common concern among patients in Newport Beach, Orange County, Los Angeles, and across California
Pulipati S, Puttagunta SB, S KV, et al
GLP-1 drugs are also showing promise for many other conditions, including fatty liver disease
For instance, a randomized controlled trial published in the "Journal of Clinical Endocrinology & Metabolism" found that individuals treated with GLP-1 receptor agonists experienced greater weight loss compared to the control group
As a result the company was forced to reduce its production of liraglutide for diabetes which had a major knock-on effect on diabetics' access to the treatment
